STOP THE WAR! Let’s support Ukraine Together

The Latest SPAC News and Rumors: October 4, 2022

latest-news

The Latest SPAC News and Rumors: October 4, 2022

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Redwire back on acquisition trail with deal for QinetiQ Space and Footprint showcases development of plant-based recyclable packaging for Gillette


Redwire back on acquisition trail with deal for QinetiQ Space

British defense firm QinetiQ is selling its Belgian commercial satellite systems division to Redwire, a U.S.-based ...READ MORE

Pathfinder Acquisition Corporation (PFDR) to Combine with Movella in $537M Deal

Pathfinder (NASDAQ:PFDR) has entered into a definitive agreement to combine with motion-capture technology firm Movella at an enterprise value of $537 million, or 13.4x its 2022E revenue. San Jose, California-based Movella provides motion-capture hardware and software for the entertainment, health and manufacturing industries. The combined company is expected to trade on the Nasdaq once the
Read More
To access this post, you must purchase 1 - User: Monthly Plan or 1 - User: Annual Plan ($250/month).
Teaser

Altitude Acquisition Corp. (ALTU) Teases $480 Million Deal

Altitude Acquisition Corp. (NASDAQ:ALTU) announced this morning that it has entered into negotiations to combine with a global medical device manufacturer that would value the deal at $480 million.

The potential target remains unnamed, but Altitude did disclose that the company is a leader in the medical device field and has a product that is commercially available and approved for use in over 30 countries. ...READ MORE

liquidation
IPO-Pricing
liquidation

Austerlitz I and II (AUS, ASZ) File to Liquidate Early

Austerlitz I (NYSE: AUS) and Austerlitz II (NYSE: ASZ) both filed proxies this afternoon stating that their sponsors are seeking shareholder approval to liquidate early.

The sponsors, Cannae Holdings, Inc. (NYSE: CNNE) and Trasimene Capital Management, believe that a completion of a suitable merger is highly unlikely, and it would be in the shareholders’ best interests to return the cash in trust in 2022 rather than wait for expiration in 2023. ...READ MORE

Freedom Acquisition 1 Corp. (FACT) to Combine with Complete Solaria in $553M Deal

Freedom I (NYSE:FACT) has entered into a definitive agreement to combine with solar services company Complete Solaria at an enterprise value of $553 million, or 4.6x its 2022E revenue. Complete Solaria is to be a combination of two California-based residential solar technology companies. The combined company is expected to trade on the NYSE under the
Read More
To access this post, you must purchase 1 - User: Monthly Plan or 1 - User: Annual Plan ($250/month).
latest-news

TradeUP (UPTD) to Combine with Estrella Biopharma in $398M Deal

TradeUP (NASDAQ:UPTD) has entered into a definitive agreement to combine with biopharma firm Estrella at a pro forma equity valuation of about $398.5 million. Emeryville, California-based Estrella is developing three potential cancer therapies aimed at improving the effectiveness of T-cell treatments. The combined company is expected to trade on the Nasdaq once the deal is
Read More
To access this post, you must purchase 1 - User: Monthly Plan or 1 - User: Annual Plan ($250/month).

LanzaTech Secures $500M Partnership for AMCI II (AMCI) Deal

AMCI II (NASDAQ:AMCI) target LanzaTech, an innovative Carbon Capture and Transformation (“CCT”) company, announced this morning that it has secured a $500 million partnership for its proposed business combination.

The sustainable materials-maker will partner with Brookfield Renewable, and its institutional partners, to co-develop and build new commercial-scale production plants that will utilize LanzaTech’s CCT technology. ...READ MORE

Teaser
SPAC-Terms-Tracker

SPAC IPO Terms Tracker: Wrapping Up Q3

Oct 1, 2022 INTEL by sam.beattie
Terms Tracker for the Week Ending September 30th, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. For the last week of the third quarter, there were zero new S-1 registration statements and two IPOs. September has ended the month with just
Read More
To access this post, you must purchase 1 - User: Monthly Plan or 1 - User: Annual Plan ($250/month).
lock-ups

SPAC Lock-Up Expirations to Watch in October

The pace of lock-up expirations is cooling with the weather as the month of October is set to see just six target companies and nine sponsors newly free to trade. These de-SPACs enter October following the worst September for stocks overall since 2008. As such, it’s far from the best time for newly released shareholders
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
latest-news

The Latest SPAC News and Rumors: September 30, 2022

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Billtrust surges on go-private deal, and Robinhood trader ‘deceived’ by Nikola founder snubs SEC filings


FinTech IPO Index Flat as Billtrust Surges on Go-Private Deal

Tech stocks have had a reckoning in the past several days — a rally proved short lived, a blip. ...READ MORE

asia-innovations-logo-2

Magnum Opus (OPA) to Combine with Asia Innovations

Magnum Opus (NYSE:OPA) has entered into a definitive agreement to combine with consumer internet company Asia Innovations Group Limited (“ASIG”) at an equity valuation of $2.5 billion. Singapore-based Asia Innovations is a mobile social company serving over 400 million registered users located in over 150 countries and regions worldwide. The combined company is expected to trade under
Read More
To access this post, you must purchase 1 - User: Monthly Plan or 1 - User: Annual Plan ($250/month).

Summit Healthcare Acquisition Corp. (SMIH) to Combine with YS Biopharma in $1Bn Deal

Summit (NASDAQ:SMIH) has entered into a definitive agreement to combine with drug-maker YS Biopharma at an enterprise value of $1.08 billion, or about 15.2x its 2022E revenue. The Beijing-based company currently makes a rabies vaccine for the Chinese market and is working to commercialize a range of new vaccines and other treatments. The combined company
Read More
To access this post, you must purchase 1 - User: Monthly Plan or 1 - User: Annual Plan ($250/month).
TOP-3